(0)
Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs)
Builds on successful track record of earlier Growth Funds which have deployed US$150 million to back emerging category leaders including omni-channel healthcare and education solutions, next generation therapeutics, and precision medicine
With first close anchored by impact-conscious investors Tsao Family Office and IMC Group, Fund III will go beyond seeking commercial returns to align intentionality and track material impact metrics that are collinear to scaling business and impact goals at the same time.